Drugs that target amyloid beta proteins in the brain likely have no clinically meaningful positive effects, while increasing ...

Anti-amyloid drugs likely provide no "clinically meaningful" effects for people with Alzheimer's, the authors concluded.

A new medical review finds "trivial" benefits for amyloid drugs. See why U.S. experts say these findings may not tell the ...

A new systematic review of 17 clinical trials found that drugs targeting amyloid beta proteins are likely to have no ...

Try side sleeping to boost your brain’s nightly cleanup—research shows it may clear Alzheimer’s-linked proteins more ...

A new study challenges the long-standing view that Alzheimer’s is driven primarily by amyloid plaques, instead pointing to a ...

Oligodendrocytes are an important source of amyloid beta (Aβ) and play a key role in promoting neuronal dysfunction in Alzheimer's disease (AD), according to a study published July 23, 2024 in the ...

Please provide your email address to receive an email when new articles are posted on . Decreased levels of plasma amyloid beta 42 at midlife, but not late life, correlated with an increased risk for ...